Key Takeaways
- Incidental diagnoses now represent a substantial proportion of resectable lung cancers, underscoring that current risk-based screening is failing to systematically identify early-stage disease.
- USPSTF criteria (age 50–80, ≥20 pack-years, quit ≤15 years) exclude growing at-risk populations, including long-term former smokers, occupational exposure cohorts, and predisposed ethnic groups.
- Contemporary thoracic surgery leveraging VATS/robotics and segmentectomy enables curative, lung-sparing management with reduced morbidity, but only when tumors are detected at an early stage.
- Photon-counting CT offers higher spatial resolution and improved contrast-to-noise at lower radiation doses, potentially reducing false positives and weakening historical objections to broader LDCT deployment.
- Legislative efforts such as the Increasing Access to Lung Cancer Screening Act, coupled with data-driven eligibility expansion, aim to shift practice from serendipitous discovery to intentional detection.
As physicians, we are guided by data, evidence-based guidelines, and a commitment to early detection. Yet, a growing clinical phenomenon—the incidental finding of early-stage lung cancer—suggests a significant gap in our current screening paradigm. A recent case at our institution is illustrative: a woman aged 70 years, with a smoking cessation history of over 50 years, underwent a routine cardiac calcium scan. This non–lung-focused imaging incidentally revealed a pulmonary nodule, which, upon follow-up and surgical resection, was confirmed to be a stage IA adenocarcinoma. This patient, whose cancer was eminently treatable due to its early discovery, falls well outside the current US Preventive Services Task Force (USPSTF) screening criteria.
Her case is not an anomaly but rather a sentinel event, representative of a cohort we are increasingly encountering. Studies corroborate this, with some estimates suggesting that up to two-thirds of surgically resected lung cancers are now discovered incidentally rather than through intentional screening. This reliance on serendipity for the nation’s leading cause of cancer death is an untenable strategy. Although adherence to screening for breast and colorectal cancers is robust, lung cancer screening languishes, with only an estimated 20% of eligible patients participating. The issue is 2-fold: overcoming barriers for the eligible and, more critically, questioning the very definition of eligibility. The current USPSTF guidelines—requiring a 20 pack-year history for adults aged 50 to 80 years who currently smoke or have quit within the past 15 years—inherently exclude a significant and growing population of at-risk individuals, including long-term former smokers, those with occupational exposures, and certain ethnic groups with a higher predisposition to lung cancer, irrespective of smoking history.
Read full article: https://www.onclive.com/view/rethinking-lung-cancer-screening-paradigms
